Additional symptoms including fatigue, cold intolerance, and reduced physical activity further compound weight management difficulties
Understanding the Dynamics: While awaiting concrete clinical data, member anecdotes suggest a notable reduction in overall alcohol cravings and intake with GLP-1 medications
Efficacy and safety of mazdutide in Chinese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial
Severe or prolonged chills could indicate an infection, thyroid dysfunction unrelated to tirzepatide, or an individual sensitivity that requires dose adjustment or medication change
Chronic study with BRK-013 BioKier completed a four-week clinical study with BKR-013 (L-glutamine in colon-targeted, sustained-release capsules) in Type 2 diabetes patients, who were already being treated with approved anti-diabetes drugs